Questions, answered carefully.
We're deliberate about what analytical verification establishes — and what it does not.
No. Bond Street Testing does not sell peptides, medications, or research compounds.
No. Bond Street Testing provides analytical verification only. Nothing on this site is medical advice, and a report is not a recommendation to use any product.
No. Identity, purity, or quantity testing does not establish medical safety, sterility, legality, or suitability for human use.
No — and that's deliberate. Bond Street Testing is an independent testing service, not a lab. We handle sample intake, chain-of-custody, and reporting, and route each sample to a licensed, accredited laboratory in our network. Keeping testing separate from any single lab — and assigning samples at random — is what keeps results impartial.
Independence. If we ran our own bench, we could be leaned on the same way an in-house COA can. By routing samples at random across a network of licensed, accredited partner laboratories, no vendor, manufacturer — or even Bond Street Testing — can pre-select the lab or steer a result.
Initial demand validation is focused on GLP-1-related compounds such as tirzepatide, retatrutide, semaglutide, and cagrilintide.
Yes. Vendors can join the batch verification waitlist to submit batches for independent testing and receive QR-verifiable batch reports.
Still have a question?
We're happy to help — whether you're an individual, a clinic, a vendor, or a prospective laboratory partner.
Contact us